Don't miss out on Monday 4th November 2024, when TG Therapeutics (NASDAQ: TGTX) will disclose its third quarter financial results before market open. Investors will have the chance to learn more about the company's performance during the quarter.
According to the predictions of financial experts on Wall Street, the company is set to unveil an estimated $0.03 profit per share for the quarter. Additionally, the company is expected to report a total revenue of $81.71 million for the specific period.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share income of $0.73. Notably, the company's total revenue reached an impressive $165.82 million during that specific period.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $327.72 million. Additionally, they are expecting the company to achieve per share profit of $0.15 for the fiscal year.
In addition, The firm will review the third quarter financial results on 4th November 2024 at 08:30 AM eastern time, in a conference call with public.
TG Therapeutics (TGTX) closed Friday's regular trading session at $26.90, marking a 7.34 percent gain. The stock fluctuated between $25.14 and $26.99 during the day, with a volume of 5.68 million shares.
